Fortrea Holdings Inc. - FTRE

SEC FilingsOur FTRE Tweets

About Gravity Analytica

Recent News

  • 02.11.2026 - Accelerating Oncology - Inside the EPON Network
  • 02.11.2026 - Unlocking CNS insights: Continuous CSF sampling in first-in-human Alzheimer’s trials
  • 02.11.2026 - Epigenetic MoA drug development: Navigating regulatory barriers to enable an hAME study in healthy volunteers
  • 02.11.2026 - Radiogenomics: Revolutionizing Clinical Trials and Precision Medicine
  • 02.04.2026 - Seeing the future: How Fortrea is shaping the next chapter in ophthalmology trials
  • 02.04.2026 - Swiss Biotech Day 2026
  • 02.04.2026 - Clinical trial execution: Reimagine each step to drive productivity gains
  • 02.04.2026 - Outsourcing in Clinical Trials Europe 2026
  • 02.03.2026 - Unlocking long-term value: Clinical trial productivity considerations for emerging biotechs
  • 02.02.2026 - Driving speed and scale: More than 20 Phase I and Ib obesity studies completed on time

Recent Filings

  • 02.10.2026 - 144 Report of proposed sale of securities
  • 02.10.2026 - 144 Report of proposed sale of securities
  • 01.20.2026 - 144 Report of proposed sale of securities